Witty Health Launches Patient Registration for OncoPower, a Blockchain-Based Global Oncology Platform

Share Article

Oncologist-designed OncoPower Rewards Patient Engagement and Compliance with Cryptocurrency Incentivization to Help Improve Cancer Care

Cancer is a very complex condition. We like the fact that OncoPower is an autonomous project that can bring together the smartest minds to improve cancer care and drug development.

Witty Health Inc., a digital therapeutic pharmaceutical company, announces secure patient registration is now open for OncoPower, an oncologist-designed online global ecosystem that utilizes blockchain technology to help improve cancer care and precision drug development by incentivizing participants with the cryptocurrency Onco.

OncoPower is a community-managed platform designed to grow an incentivized global cancer care network. It is a self-governing, autonomous ecosystem entirely managed by its community stakeholders including oncologists, patients, and caregivers. OncoPower is a HIPAA-compliant system including a secure Onco-Klinic for clinical care as well as Onco-Space, a patient support and advocacy feature which utilizes a Social Determinants of Health approach. Patients who join OncoPower during this pre-registration period will receive Oncos as incentives for use on the platform.

"We are excited to introduce the patient registration platform as we continue to advance the development of this autonomous ecosystem," said Witty Health Co-Founder Ram Sesha. "According to IMS and Global Research, the global oncology market participants are projected to spend $150 billion in medications and $120 billion on diagnostics by 2020. There are significant opportunities to improve efficiency, delivery of care, and outcomes by adopting data driven value-based care."

Onco-Klinic will help users build a complete patient treatment history and reward patients for sharing data and content. The platform also enables smart-contracts between payers-providers, payers-patients, and payers-pharmaceutical brands with the goal of improving outcomes, medication adherence, and data reporting during cancer treatment. The Onco-Klinic is an enhanced version of Witty Health's Smart Cancer Treatment Platform (SmartCTP™) which is under clinical development.

Onco-Space is a secure support platform connecting patients with caregivers including patient advocates, registered dietitians, behavioral therapists, geneticists, financial counselors, and subject experts. It enables smart contracts for services between patients and caregivers, removing brokering agencies. More importantly, Onco-Space will let subject experts post content which is reviewed, rated, and rewarded with Onco cryptocurrency. Thus Onco-Space will be a place for patients to find authentic, curated and reliable information. Onco-Space will also allow patients to connect with qualified caregivers without having to search the internet and other unsecured sources.

"Secure patient data sharing is a major concern and one of the toughest challenges facing oncologists when care collaboration is imperative to improving quality of life and outcomes for cancer patients. This is an open source project and anybody can develop applications, contribute and benefit by creating value," stated Dr. Karthik Koduru, chief oncologist, co-founder and board member, Witty Health.

OncoPower is powered by a blockchain-integrated incentive called Onco, an ERC20-compliant cryptocurrency that will encourage quality content, power all platform actions, and serve as the fuel of the tokenized Onco-economy. Onco is generated at every transparent, pre-programmed block production and a majority of the generated Onco goes to a reward pool for distribution to value creators. This builds long-term growth of the ecosystem and keeps the value within the Onco-economy.

OncoPower is a truly autonomous oncology ecosystem by giving Onco token holders real power over the direction of the platform. With OncoPower, the participants are both owners and consumers. They retain both the clinical and social benefits and most of the financial benefit which is distributed proportionate to their contribution using transparent consensus algorithms. The open source design enables any health system or provider to leverage our blockchain, incentive mechanism and our user base.

"Cancer is a very complex condition. We like the fact that OncoPower is an autonomous project that can bring together the smartest minds to improve cancer care and drug development," practicing oncologists and advisers to Witty Health Muhammad Omer Jamil, MD of Marshall Health in Huntington, West Virginia; Manoj Reddy, MD of Baylor Medical Center at Frisco, Texas; and Govardhanan Nagaiah, MD of HonorHealth Scottsdale Shea Medical Center in Scottsdale, Arizona said in a joint statement.

In addition, the project benefited from the healthcare industry knowledge and clinical expertise of a number of practicing physicians and specialists who serve as advisers to Witty Health including: Tommy Ibrahim, MD, Joseph Awotwi, MD, Joel Ward DO, Sean Brimacombe MD, Susheel Gundewar, MD, Raghu Kolluri, MD and Subbarao Myla MD.

About OncoPower
OncoPower is an oncologist-designed, self-governing system that has been developed to autonomously and perpetually create value for the global cancer community through an incentivized approach using the cryptocurrency Onco. It is largely owned and entirely managed by its community stakeholders. OncoPower is a HIPAA-compliant ecosystem including a secure Onco-Klinic for clinical care and Onco-Space for patient support and advocacy which utilizes a Social Determinants of Health (SDoH) approach. It is powered by Onco- a cryptocurrency as a medium of exchange to create reward value and facilitate smart contracts between community participants. OncoPower was developed by Witty Health, Inc. (http://www.wittyhealth.com), a Houston-based technology company focusing on intelligence-powered, real-time health risk monitoring solutions to improve cancer care.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Tara DiFlumeri
Visit website